CHD

Church & Dwight (CHD) is a large-cap Consumer Defensive name priced like a premium staples compounder. With the stock near its 50-day EMA and its next earnings report set for October 30, 2026, the numbers below are worth unpacking for anybody trying to understand the company rather than chase a headline.

Business profile & competitive position

Church & Dwight Co., Inc. operates in the Consumer Defensive sector, specifically the Household & Personal Products industry. It develops, manufactures, and markets consumer household and personal care products, along with specialty products focused on animal nutrition, specialty chemicals, and commercial/professional cleaners. Its brand list is a roster of household staples: ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, and ZICAM. The company reports through three divisions: Consumer Domestic, Consumer International, and Specialty Products Division.

The competitive story starts with two key figures: a net margin of 12.0% and a return on equity of 17.8%. The ROE is the more telling number. A mid-teens ROE indicates that the business can reinvest capital profitably, which is exactly what you would expect from a portfolio dominated by repeatedly purchased, brand-led products. A 12.0% net margin is not the widest in all of consumer staples, but paired with that ROE it points to capital efficiency rather than brute-force scale. The concentration in seven power brands, which represented approximately 70% of consolidated net sales and profits in 2025, reinforces that the moat rests on a handful of trusted names more than on a sprawling, low-differentiation commodity business.

Financial posture

Church & Dwight’s current market capitalization is $23.4 billion, and the stock trades at a P/E ratio of 31.6. That multiple is elevated by consumer-staples standards, so the market is clearly assigning a scarcity or quality premium to the earnings stream. The flip side is that there is less margin of safety baked in than for a lower-multiple peer if growth or interest-rate expectations shift.

Profitability and volatility metrics support part of the premium. The 12.0% net margin and 17.8% ROE show a business that is still translating sales into bottom-line results and shareholder returns. The beta is just 0.47, meaning CHD has historically moved less than half as much as the broader market, consistent with the defensive, recession-resistant profile typical of household-products companies. Debt and leverage are not specified in the current data set, so any complete balance-sheet assessment would need to layer in the latest debt figures before drawing firm conclusions about financial risk.

Strategic priorities & outlook

The company’s most recent 10-K filing lays out a clear operating agenda. Management is repositioning the portfolio toward faster-growing value and premium product lines, following the exits of Flawless, Spinbrush, the Waterpik showerhead business, and the VMS brands. The integration of the Touchland hand-sanitizer acquisition is another near-term priority, with management focused on realizing its intended contribution to sales and earnings.

Longer term, Church & Dwight wants to expand its seven power brands globally, citing significant expansion potential outside the United States. That strategy also highlights concentration risk: the same seven power brands represented roughly 70% of consolidated net sales and profits in 2025. Supply-chain resiliency is another stated priority, with the company maintaining qualified dual sources for approximately 70% of direct materials spend.

Customer concentration is worth watching. Walmart accounted for about 23% of consolidated net sales in 2025, and no other customer exceeded 10% over the past three years. Within the Consumer Domestic segment, household products represented approximately 54% of segment net sales in 2025, while personal care products contributed about 46%.

Macro & geopolitical exposure

The Household & Personal Products industry is classic defensive territory. Demand for detergent, oral care, condoms, and dry shampoo does not normally collapse during recessions, which is consistent with CHD’s low 0.47 beta. But defensive positioning does not mean absence of macro exposure.

Input cost volatility is a persistent factor: surfactants, resins, packaging films, fragrances, and specialty chemicals can move with oil, commodity, and freight markets, pressuring margins even if unit volume remains steady. International expansion exposes reported results to currency translation and to local competitive dynamics in markets where brand strength may differ from the U.S. Regulatory scrutiny is also a staple of this sector, including FDA and FTC oversight of health claims, personal-care ingredients, labeling, and environmental packaging rules. Retail buyer concentration, illustrated by Walmart’s roughly 23% share of sales, is another macro-like variable. Finally, trade policy and tariffs on imported inputs or finished goods can affect any company with global sourcing and manufacturing, even if the specific tariff exposure is not quantified here.

Recent developments

The recent headlines around CHD are quiet on operations but active on capital flows. On September 1, 2026, Beacon Pointe Advisors LLC reported a new $742,000 investment in Church & Dwight, according to defenseworld.net. On August 31, 2026, the same outlet noted that Corient Private Wealth LP also made a new investment in the stock. On the same day, 247wallst.com included CHD in a piece on consumer staples stocks that keep raising dividends, and invezz.com covered a Bank of America note on stocks with meaningful upside in September—readers would need to verify whether CHD was specifically named on that list.

There is no headline here about a restructuring, management change, or guidance reset. The news flow is consistent with wealth managers and income-oriented screens treating CHD as a defensive allocation rather than a catalyst-driven trade.

Earnings behavior & post-earnings drift

Church & Dwight has a strong headline earnings record. Over the last eight reported quarters, it beat analyst EPS estimates six times, an 86% beat rate, with an average earnings surprise of 5.2%. Across those same quarters, the average five-day price move after the report is 1.32% to the upside.

However, the real analyst takeaway is that beats have not always translated into follow-through. In the four most recent quarters, three were beats, yet the reaction was inconsistent. On October 31, 2025, the company reported $0.81 versus a $0.736 estimate, a 10.1% positive surprise, but the stock dropped 1.61% the next day and finished the next five days down 0.95%. On January 30, 2026, EPS of $0.86 beat the $0.836 estimate by 2.9%, and the stock rose 1.13% the next session and 4.45% over the following five days.

On May 1, 2026, EPS of $0.95 beat the $0.931 estimate by 2%, yet the stock fell 3.26% the next day and was down 2.69% five days later. The most recent report, on July 31, 2026, was a slight miss—actual EPS of $0.89 versus an estimate of $0.896, a -0.7% surprise—but the stock still rose 1.21% the next day and 4.48% over the following five days. With the next earnings date scheduled for October 30, 2026, before the market opens and the consensus EPS estimate at $0.90, the data argue against a simplistic “beat equals pop” playbook.

Technically, the current snapshot at $98.55 places CHD just below its 50-day EMA of $99.35, with an RSI of 43.9—neutral territory that offers neither an overbought nor oversold signal heading into the report.

For a deeper dive into Church & Dwight, including how sell-side ratings, price targets, and institutional holdings stack up against the numbers above, review the full institutional verdict on the ticker page.